Showing results (421-430 of 635) with videos related to

Sort By:
Pageof 64
The Journal of Pathology|May 1, 2018
CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancerStephan Bartels, Jana Lisa van Luttikhuizen, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine ResistanceSophie Mueller, Isabel Grote, Stephan Bartels, et al.
Case Reports in Gastroenterology|January 14, 2021
Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-CholangiocarcinomaSven H Loosen, Nadine T Gaisa, Maximilian Schmeding, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2019
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancerSteffen Dietz, Petros Christopoulos, Lisa Gu, et al.
European Urology Focus|March 18, 2019
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active SurveillanceSvenja Dieffenbacher, Joanne Nyarangi-Dix, Francesco Giganti, et al.
Cancers|September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas CancerLukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Urologic Oncology|July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
Investigative Radiology|May 28, 2021
Fully Automatic Deep Learning in Bi-institutional Prostate Magnetic Resonance Imaging: Effects of Cohort Size and HeterogeneityNils Netzer, Cedric Weißer, Patrick Schelb, et al.
Oncoimmunology|February 4, 2025
Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination siteMaria Paula Roberti, Pornpimol Charoentong, Yanhong Lyu, et al.
BMC Cancer|August 31, 2017
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocolJacek Hajda, Monika Lehmann, Ottheinz Krebs, et al.
Pageof 64